HbA1c alone may mislead diabetes diagnosis: Study
India’s over-reliance on glycated haemoglobin (HbA1c) test alone for diagnosing and monitoring type-2 diabetes could result in underdiagnosis, delayed treatment and avoidable complications for millions, according to a new study published in The Lancet Regional Health-Southeast Asiaon Monday.
India’s over-reliance on glycated haemoglobin (HbA1c) test alone for diagnosing and monitoring type-2 diabetes could result in underdiagnosis, delayed treatment and avoidable complications for millions, according to a new study published in The Lancet Regional Health-Southeast Asiaon Monday.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
